ENDOCRINOLOGY

Atypical femoral fractures

Sep 21, 2024 by in ENDOCRINOLOGY Comments Off on Atypical femoral fractures

Learning objectives • Recognize the symptoms and presentation of atypical femoral shaft fractures (AFF). • Understand the pathophysiology of AFF and the role of antiresorptive medication. The case study Reason…

read more

Parathyroid hormone analogs

Sep 21, 2024 by in ENDOCRINOLOGY Comments Off on Parathyroid hormone analogs

Teriparatide/abaloparatide—Part I: Differences and similarities Learning objectives • Pharmacologic profile: efficacy and adverse effects of teriparatide and abaloparatide. • Teriparatide and abaloparatide: differences and similarities. • Impact of recent label…

read more

Sclerostin inhibitor (SERM): Romosozumab

Sep 21, 2024 by in ENDOCRINOLOGY Comments Off on Sclerostin inhibitor (SERM): Romosozumab

Learning objectives • Understand bone turnover, its various components, and how they can be manipulated. • Recognize the role of sclerostin and romosozumab in bone turnover. • Identify patients who…

read more

Sclerostin inhibitor (SERM): Raloxifene

Sep 21, 2024 by in ENDOCRINOLOGY Comments Off on Sclerostin inhibitor (SERM): Raloxifene

Learning objectives • Raloxifene: Therapeutic profile: efficacy and adverse effects. • Estrogen/progesterone: uses, limitations, adverse effects. The case study Reason for seeking medical help Mrs. KA, 65-year-old woman is concerned…

read more

Drug holidays

Sep 21, 2024 by in ENDOCRINOLOGY Comments Off on Drug holidays

Learning objectives • “Drug holidays” refer to the discontinuation—temporary or permanent—of bisphosphonate therapy following a 3- to 5-year period of continuous therapy whether oral or IV. • Determine whether to…

read more

Zoledronic acid—Annual infusions

Sep 21, 2024 by in ENDOCRINOLOGY Comments Off on Zoledronic acid—Annual infusions

Learning objectives • Osteoporosis is silent until a fracture is sustained. • Osteoporosis is underdiagnosed and undertreated. • The pharmacologic profile of zoledronic acid: efficacy and adverse effects. The case…

read more

Oral bisphosphonates—Lack of response

Sep 21, 2024 by in ENDOCRINOLOGY Comments Off on Oral bisphosphonates—Lack of response

Learning objectives • Evaluation of patients on long-term bisphosphonate therapy for drug resistance. • Recognize lifestyle habits that can interfere with bisphosphonate efficacy. The case study Reasons for seeking medical…

read more

Oral bisphosphonates—Long term: 13 years

Sep 21, 2024 by in ENDOCRINOLOGY Comments Off on Oral bisphosphonates—Long term: 13 years

Learning objectives • Evaluation of patients on long-term antiresorptive therapy. • When and how to discontinue long-term bisphosphonate therapy. The case study Reasons for seeking medical help • VP is…

read more
Get Clinical Tree app for offline access